Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials-Reference-Cited by-同舟云学术

Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials

Published:2023-05-17 Issue:4 Volume:24 Page:595-607
ISSN:1175-0561
Container-title:American Journal of Clinical Dermatology
language:en
Short-container-title:Am J Clin Dermatol

Author:

Stein Gold Linda,Thaçi Diamant,Thyssen Jacob P.,Gooderham Melinda,Laquer Vivian,Moore Angela,Natalie Chitra R.,Zhao Fangyi,Meskimen Eric,Elmaraghy Hany,Montmayeur Sonia,Gallo Gaia,Jimenez Gemma,de Bruin-Weller Marjolein

Funder

Eli Lilly and Company

Publisher

Springer Science and Business Media LLC

Subject

Dermatology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40257-023-00792-6.pdf

Reference40 articles.

1. Harrop J, Chinn S, Verlato G, et al. Eczema, atopy and allergen exposure in adults: a population-based study. Clin Exp Allergy. 2007;37:526–35.

2. Sacotte R, Silverberg JI. Epidemiology of adult atopic dermatitis. Clin Dermatol. 2018;36:595–605.

3. Saeki H, Tsunemi Y, Fujita H, et al. Prevalence of atopic dermatitis determined by clinical examination in Japanese adults. J Dermatol. 2006;33:817–9.

4. Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020;396:345–60.

5. Chiesa Fuxench ZC, Block JK, Boguniewicz M, et al. Atopic dermatitis in America study: a cross-sectional study examining the prevalence and disease burden of atopic dermatitis in the US adult population. J Invest Dermatol. 2019;139(3):583–90.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of interleukins in dermatology: Exploring the immune mechanisms in skin diseases;JEADV Clinical Practice;2024-09

2. Consensus Recommendations for the Management of Atopic Dermatitis in the United Arab Emirates;Dermatology and Therapy;2024-08-22

3. A Comprehensive Review of Biologics in Phase III and IV Clinical Trials for Atopic Dermatitis;Journal of Clinical Medicine;2024-07-09

4. Monoclonal Antibodies: Current Advancements and Future Potential for Atopic Dermatitis Therapy;Current Pharmaceutical Biotechnology;2024-06-25

5. Interleukin antagonists for atopic dermatitis: a new era of therapy;Expert Opinion on Investigational Drugs;2024-06-02